Paul Mampilly is the founder of Profits unlimited, a newsletter under the umbrella of Banyan Hill Publishing. Mampilly joined Banyan Hill in 2016. He recently wrote a new article for the newsletter claiming he had knowledge of what could be the greatest medical breakthrough in history. Many think this is just a ploy from Mampilly in order to draw in more subscribers. So far though, he has been adamant in saying he’s identified the company leading the precision medicine revolution. Could there be any truth in what the former hedge fund manager is saying.
The Auto Industry Is About to Completely Change.#AutonomousVehicles #AutonomousCars #Waymo #driverlesscars #technology #ridesharing #banyanhill #Automotive #Automotive $F $GM $FCAUhttps://t.co/zzn3rNnpRd
— Paul Mampilly (@Paul_M_Guru) November 9, 2017
According to Mampilly, a company with an estimated value of $1.5 billion in getting ready to take the health care market by storm. Though he only provided teaser information he did disclose that it is involved in precision medicine. What is precision medicine? Well in layman’s terms think of having the ability to customize medicine in a way to fit a person’s unique genetic makeup. It may sound a bit like science fiction but in truth there are many companies involved with precision medicine. Precision medicine can not only treat illnesses it can also prevent them which is even more important.
The company Mampilly is supporting so strongly is Utah-based Myriad Genetis (MYGN). The company is a hilltop facility consisting of some of the top scientific minds and biotech pioneers in the industry. It is an industry leader when it comes to molecular diagnostic DNA sequencing. while the company’s stock has been doing well as of late it will be interesting to see if it makes the kind of impact Mampilly is predicting someday.
About Paul Mampilly
Before Mampilly founded Profits Unlimited he was thriving on Wall Street as an investor. During this time he also held high ranking positions at Deutsche Bank and ING. In 2006 he became the hedge fund manager of Kinetics Asset Management. At the time the firm was worth $6 billion. With Mampilly at the helm its assets quadrupled.
Paul left Wall Street when he realized he had a passion for helping others become financially free. He is still an investor he just no longer makes money for the ultra rich.
Learn More: ideamensch.com/paul-mampilly/